Home Carboxes 1311315-85-1
1311315-85-1,MFCD18785597
Catalog No.:AA009YI1

1311315-85-1 | benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$111.00   $78.00
- +
250mg
95%
in stock  
$189.00   $133.00
- +
500mg
95%
in stock  
$315.00   $221.00
- +
1g
95%
in stock  
$474.00   $332.00
- +
5g
95%
in stock  
$1,413.00   $989.00
- +
10g
95%
in stock  
$2,092.00   $1,465.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA009YI1
Chemical Name:
benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate
CAS Number:
1311315-85-1
Molecular Formula:
C11H12ClNO4S
Molecular Weight:
289.7353
MDL Number:
MFCD18785597
SMILES:
O=C(N1CC(C1)S(=O)(=O)Cl)OCc1ccccc1
Properties
Computed Properties
 
Complexity:
394  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Rotatable Bond Count:
4  
XLogP3:
1.6  

Downstream Synthesis Route

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1

[3]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1

[1]Synthesis,2011,p.3669-3674

[2]Patent:WO2017/40757,2017,A1

[3]Patent:WO2018/102419,2018,A1

[4]Patent:US2018/271837,2018,A1

[1]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1Locationinpatent:Paragraph0329;0337;0338;0339

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[3]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[4]Locationinpatent:experimentalpartZhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[5]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1Locationinpatent:Paragraph00485

[6]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US2018/271837,2018,A1Locationinpatent:Paragraph0167-0168

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2020/58913,2020,A1Locationinpatent:Page/Pagecolumn42

[1]Grygorenko,OleksandrO.;Zhersh,Sergey;Oliinyk,BohdanV.;Shishkin,OlegV.;Tolmachev,AndreyA.[TetrahedronAsymmetry,2014,vol.25,#3,p.229-237]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1311315-85-1 Molecular Formula|1311315-85-1 MDL|1311315-85-1 SMILES|1311315-85-1 benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate